ACELRX PHARMACEUTICALS INC (ACRX)

US00444T2096 - Common Stock

0.86  +0.06 (+7.5%)

After market: 0.8719 +0.01 (+1.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
620.00K1.77M2.82M5.42M2.29M
Cost Of Goods
N/A2.59M3.75M6.03M6.81M
Gross Profit
N/A-820.00K-940.00K-620.00K-4.52M
Operating Expenses
20.26M30.86M35.03M40.35M49.68M
Research and Development
4.81M5.19M4.10M4.02M4.66M
Selling, General, and Administrative Expenses
15.45M25.67M30.94M36.33M45.03M
Operating Income
-19.99M-31.68M-35.97M-40.96M-54.21M
Interest Income/Expense
6.77M-790.00K-2.17M-2.72M-370.00K
Other Income/Expense
0.0085.19M3.04M3.31M1.34M
Non Recurring Items
N/A-4.95MN/AN/AN/A
Income Before Taxes
-13.28M47.77M-35.09M-40.38M-53.24M
Income Tax
N/A10.00K10.00K0.000.00
Net Income
-26.48M42.33M-35.10M-40.38M-53.24M
EBITDA
N/A-30.03M-34.00M-39.11M-52.54M
 
Per Share Data
EPS Diluted Total Ops
-2.905.71-5.86-9.47-13.45
Non GAAP EPS
-2.23-4.34-5.80-9.60-13.40
 
Statistics
Gross Profit Margin
N/A-46.33%-33.33%-11.44%-197.38%
Profit Margin
-4270.97%2391.53%-1244.68%-745.02%-2324.89%
Operating Profit Margin
-3224.19%-1789.83%-1275.53%-755.72%-2367.25%

All data in USD

Charts